(Q39443274)

12 September 2017

Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy (English)

1 reference

12 September 2017

1 reference

2

1 reference

12 September 2017

Joana Magalhães

1

1 reference

12 September 2017

1 December 2011

1 reference

Journal of Neuropathology & Experimental Neurology

12 September 2017

1 reference

12 September 2017

70

1 reference

12 September 2017

12

1 reference

12 September 2017

1097-1106

1 reference

A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves

12 September 2017

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Activation of the heat shock response in familial amyloidotic polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Quality control of protein folding in extracellular space

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Clusterin is a secreted mammalian chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Stress-induced transcription of the clusterin/apoJ gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Clusterin solubility and aggregation in Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Serum clusterin levels are not increased in presymptomatic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Apolipoprotein J and Alzheimer's amyloid beta solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Extracellular chaperones modulate the effects of Alzheimer's patient cerebrospinal fluid on Abeta(1-42) toxicity and uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Clusterin facilitates in vivo clearance of extracellular misfolded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Congo red as a stain for fluorescence microscopy of amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Misfolded transthyretin causes behavioral changes in a Drosophila model for transthyretin-associated amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

αB-crystallin (HspB5) in familial amyloidotic polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Toxicity mediated by soluble oligomers of beta-amyloid(1-42) on cholinergic SN56.B5.G4 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Clusterin regulates transthyretin amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31823A44F4

10.1097/NEN.0B013E31823A44F4

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

22082661